MAIA Biotechnology, Inc. (MAIA)

USD 1.94

(-11.82%)

Total Debt Summary of MAIA Biotechnology, Inc.

  • MAIA Biotechnology, Inc.'s latest annual total debt in 2023 was - USD , down 0.0% from previous year.
  • MAIA Biotechnology, Inc.'s latest quarterly total debt in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • MAIA Biotechnology, Inc. reported annual total debt of - USD in 2022, down 0.0% from previous year.
  • MAIA Biotechnology, Inc. reported annual total debt of - USD in 2021, down -100.0% from previous year.
  • MAIA Biotechnology, Inc. reported quarterly total debt of - USD for 2024 Q2, down 0.0% from previous quarter.
  • MAIA Biotechnology, Inc. reported quarterly total debt of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of MAIA Biotechnology, Inc. (2023 - 2019)

Historical Annual Total Debt of MAIA Biotechnology, Inc. (2023 - 2019)

Year Total Debt Total Debt Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD -100.0%
2020 463.75 Thousand USD 1218.53%
2019 35.17 Thousand USD 0.0%

Peer Total Debt Comparison of MAIA Biotechnology, Inc.

Name Total Debt Total Debt Difference
AIM ImmunoTech Inc. 495 Thousand USD 100.0%
Ampio Pharmaceuticals, Inc. 274 Thousand USD 100.0%
Armata Pharmaceuticals, Inc. 120.37 Million USD 100.0%
Actinium Pharmaceuticals, Inc. 2.11 Million USD 100.0%
Azitra, Inc. 885.94 Thousand USD 100.0%
Can-Fite BioPharma Ltd. 39.99 Thousand USD 100.0%
Chromocell Therapeutics Corporation 1.26 Million USD 100.0%
Calidi Biotherapeutics, Inc. 7.23 Million USD 100.0%
CEL-SCI Corporation 13.57 Million USD 100.0%
iBio, Inc. 4.46 Million USD 100.0%
Lineage Cell Therapeutics, Inc. 2.95 Million USD 100.0%
Matinas BioPharma Holdings, Inc. 3.55 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. 2.43 Million USD 100.0%
NovaBay Pharmaceuticals, Inc. 2.74 Million USD 100.0%
NanoViricides, Inc. - USD NaN%
Oragenics, Inc. 312.7 Thousand USD 100.0%
BiomX Inc. 15.09 Million USD 100.0%
BiomX Inc. 15.09 Million USD 100.0%
Protalix BioTherapeutics, Inc. 26.28 Million USD 100.0%
Palatin Technologies, Inc. 590.33 Thousand USD 100.0%
Scorpius Holdings, Inc. 14.04 Million USD 100.0%